• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Gamida Cell

parachute south africa cape town
Biotech

Marea, Ashibio, Arvinas & more—Chutes & Ladders

Cardiometabolic biotech Marea unveils C-suite. Ashibio exits stealth with newly appointed leaders. Arvinas CSO steps into new role after 5 years
Gabrielle Masson , Andrea Park , Fraiser Kansteiner Jun 21, 2024 8:30am
for sale close down for sale sign business

Gamida accepts sale to investment firm to survive

Mar 27, 2024 9:53am
life raft rescue safety buoy save drowning

Cash-strapped Gamida steps up search for strategic alternatives

Jan 29, 2024 8:41am
layoffs cuts workforce reduction

Gamida lays off 17%, ditches NKs to keep omidubicel going

Mar 27, 2023 9:30am
visual of drugs being inspected by a magnifying glass

FDA extends review of Gamida Cell's approval by 3 months

Nov 22, 2022 10:55am
Rocky Path

Gamida drops mixed bag of news on FDA submission, staffing cuts

Jan 31, 2022 9:31am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings